Another CAR-T Warning; 'Sweet' Cancer Test; 'Molecular Jackhammer' Blows Up Cancer
(MedPage Today) -- Amid an ongoing investigation of CAR T-cell therapy safety, the FDA has added risk of secondary malignancies to the boxed warning for ciltacabtagene autoleucel (Carvykti). (Fierce Pharma)
Cellular and gene therapy will likely...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Cancer | Cancer & Oncology | Gene Therapy | Genetics | Hematology | Pharmaceuticals | Warnings